This inventor holds 1 USPTO granted patent. Top assignee: University of Connecticut. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Michael Van Heyst: Innovator in Histone Deacetylase Inhibitors
Introduction
Michael Van Heyst is an accomplished inventor based in Glastonbury, Connecticut. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as histone deacetylase (HDAC) inhibitors. His work is vital in the ongoing research for therapeutic agents.
Latest Patents
Michael Van Heyst holds a patent for "Substituted tropolone derivatives and methods of use." This patent describes compositions and methods that relate to substituted tropolone derivatives, which are useful in inhibiting HDAC. His innovative approach has the potential to impact various medical applications.
Career Highlights
Michael is affiliated with the University of Connecticut, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in his field. He has demonstrated a commitment to advancing scientific knowledge through his inventions.
Collaborations
Michael has collaborated with notable colleagues, including Dennis L Wright and Amy C Anderson. These partnerships have fostered a collaborative environment that enhances the research output and innovation within their projects.
Conclusion
Michael Van Heyst is a prominent inventor whose work on substituted tropolone derivatives contributes significantly to the field of medicinal chemistry. His dedication to research and innovation continues to pave the way for advancements in therapeutic applications.